Pipeline

Vaccines

  • DLV-N1
    Vaccine Type

    Personalized

    Antigen Type

    Neoantigen

    1
    2
    3
    4
    2025
    2026
    2027
    2028
    2029
    1. 1. PoC
    2. 2. CMC / CTM
    3. 3. IND Filing
    4. 4. Phase 1
  • DLV-N2
    Vaccine Type

    Personalized

    Antigen Type

    Neoantigen

    1
    2
    3
    4
    2025
    2026
    2027
    2028
    2029
    1. 1. PoC
    2. 2. CMC / CTM
    3. 3. IND Filing
    4. 4. Phase 1
  • DLV-T1
    Vaccine Type

    Personalized

    Antigen Type

    TAA

    1
    2
    3
    4
    2025
    2026
    2027
    2028
    2029
    1. 1. PoC
    2. 2. CMC / CTM
    3. 3. IND Filing
    4. 4. Phase 1
  • DLV-C1
    Vaccine Type

    Off-the-shelf

    Antigen Type

    Cryptic Antigen

    1
    2
    3
    2025
    2026
    2027
    2028
    2029
    1. 1. Target Identification
    2. 2. PoC
    3. 3. CMC / CTM

Lead the New Standard of Cancer Treatment with Neogenlogic